{
  "docId": "019de077-62f6-7619-b3d4-93c2a4cadb7d",
  "docSlug": "491e9b124c7ffd2bd1d8681cd2680c6c",
  "documentTitle": "OmniAb | Results Presentation Deck | 16 slides",
  "authorId": "omniab",
  "authorName": "OmniAb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 16,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "key_messages",
  "function": "summarize",
  "density": "sparse",
  "nDataPoints": 3,
  "notes": "The slide uses a grid layout to organize updates by partner company.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-62f6-7619-b3d4-93c2a4cadb7d/9",
  "deckHref": "/decks/019de077-62f6-7619-b3d4-93c2a4cadb7d",
  "deckJsonHref": "/decks/019de077-62f6-7619-b3d4-93c2a4cadb7d.json",
  "deckAnchorHref": "/decks/019de077-62f6-7619-b3d4-93c2a4cadb7d#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.7,
        "w": 0.9,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "list",
      "text": "Updates for Immunovant (IMVT-1402, Batoclimab), Genmab (Acasunlimab, GEN1057), BioCity (BC3195), and Teva (TEV-53408).",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a7fc70e5-6a59-4d11-bd72-d477899dfc16",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.5,
        "x": 0.05,
        "y": 0.13
      },
      "kind": "paragraph",
      "text": "RECENT DEVELOPMENTS AND UPCOMING KEY EVENTS",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "eca03613-307b-430e-9506-60f765faef9e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.4,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Select Partner Updates",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9cc9d509-6f42-4289-8964-ca898612f05d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 9,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "ef4536a9-bf42-4eb8-a5ae-6239cca5f481",
      "evidence": "Emphasis on Q3 momentum in all key metrics",
      "position": 0,
      "objective": "Highlighting the value of OmniAb's growth",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}